Drug encapsulated polymeric microspheres for intracranial tumor therapy: A review of the literature

Advanced Drug Delivery Reviews

Volumn 91, Issue , 2015, Pages 23-37

  Floyd, J Alaina ^a   Galperin, Anna ^a   Ratner, Buddy D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

5 Fluorouracil; Chemotherapeutics; Drug delivery; Emulsion; Gliomas; Localized therapy; Microspheres; Paclitaxel

Indexed keywords

CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; EMULSIFICATION; EMULSIONS; MICROSPHERES; PATIENT MONITORING; POLYMERS; TUMORS;

5-FLUOROURACIL; CHEMOTHERAPEUTICS; GLIOMAS; LOCALIZED THERAPY; PACLITAXEL;

TARGETED DRUG DELIVERY;

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CAMPTOTHECIN; CANNABINOL; CARBOPLATIN; CARMUSTINE; CELECOXIB; CHLOROETHYLNITROSOUREA; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEFITINIB; HEMOPEXIN; IDOXURIDINE; IMATINIB; INTERLEUKIN 2; MITOXANTRONE; OSTEOGENIC PROTEIN 1; PACLITAXEL; PHYTOCANNABINOID; POLY(METHYLIDENE MALONATE); POLYCAPROLACTONE; POLYGLACTIN; POLYMER; TEMOZOLOMIDE; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VATALANIB; DRUG CARRIER; MICROSPHERE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOCOMPATIBILITY; BRAIN CANCER; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER THERAPY; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL PROCEDURES; COACERVATION; DOUBLE EMULSION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; DRUG POTENCY; DRUG RELEASE; DRUG STABILITY; ELECTRODYNAMIC ATOMIZATION; ENCAPSULATION; GLIOMA; GLIOMA CELL LINE; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; INTRACRANIAL TUMOR; LOADING DRUG DOSE; MONOTHERAPY; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SINGLE EMULSION; SPRAYING TECHNIQUE; TOXICITY TESTING; TUMOR INVASION; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; ANIMAL; BRAIN NEOPLASMS; CHEMISTRY; DRUG DESIGN; GLIOBLASTOMA; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GLIOBLASTOMA; HUMANS; MICROSPHERES; POLYMERS;

EID: 84940963172     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.04.008     Document Type: Review

References (76)

1. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations) April 2012, (http://seer.cancer.gov/csr/1975_2009_pops09/). N. Howlader, N. A., M. Krapcho, N. Neyman, R. Aminou, S.F. Altekruse, C.L. Kosary, J. Ruhl, Z. Tatalovich, H. Cho, A. Mariotto, M.P. Eisner, D.R. Lewis, H.S. Chen, E.J. Feuer, K.A. Cronin (Eds.).
2. Society A.C. Cancer Fact and Figures 2012 2012.
3. Holland E.C. Glioblastoma multiforme: the terminator. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(12):6242-6244.
4. Anton K., Baehring J.M., Mayer T. Glioblastoma multiforme: overview of current treatment and future perspectives. Hematol. Oncol. Clin. North Am. 2012, 26(4):825-853.
5. Van Meir E.G., Hadjipanayis C.G., Norden A.D., Shu H.K., Wen P.Y., Olson J.J. Exciting new advances in neuro-oncology the avenue to a cure for malignant glioma. CA Cancer J. Clin. 2010, 60(3):166-193.
6. Buonerba C., Di Lorenzo G., Marinelli A., Federico P., Palmieri G., Imbimbo M., Conti P., Peluso G., De Placido S., Sampson J.H. A comprehensive outlook on intracerebral therapy of malignant gliomas. Crit. Rev. Oncol. Hematol. 2011, 80(1):54-68.
7. Alam M.I., Beg S., Samad A., Baboota S., Kohli K., Ali J., Ahuja A., Akbar M. Strategy for effective brain drug delivery. Eur. J. Pharm. Sci. 2010, 40(5):385-403.
8. Groothuis D.R. The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol. 2000, 2(1):45-59.
9. Orive G., Ali O.A., Anitua E., Pedraz J.L., Emerich D.F. Biomaterial-based technologies for brain anti-cancer therapeutics and imaging. Biochim. Biophys. Acta Rev. Cancer 2010, 1806(1):96-107.
10. Hochberg F.H., Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980, 30(9):907-911.
11. Sawyer A.J., Piepmeier J.M., Saltzman W.M. New methods for direct delivery of chemotherapy for treating brain tumors. Yale J. Biol. Med. 2006, 79(3-4):141-152.
12. Guerin C., Olivi A., Weingart J.D., Lawson H.C., Brem H. Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Investig. New Drugs 2004, 22(1):27-37.
13. Dang W.B., Daviau T., Ying P., Zhao Y., Nowotnik D., Clow C.S., Tyler B., Brem H. Effects of GLIADEL(R) wafer initial molecular weight on the erosion of wafer and release of BCNU. J. Control. Release 1996, 42(1):83-92.
14. Westphal M., Hilt D.C., Bortey E., Delavault P., Olivares R., Warnke P.C., Whittle I.R., Jaaskelainen J., Ram Z. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol. 2003, 5(2):79-88.
15. Tiwari G., Tiwari R., Sriwastawa B., Bhati L., Pandey S., Pandey P., Bannerjee S.K. Drug delivery systems: an updated review. Int. J. Pharm. Investig. 2012, 2(1):2-11.
16. Nance E., Zhang C., Shih T.Y., Xu Q.G., Schuster B.S., Hanes J. Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano 2014, 8(10):10655-10664.
17. Zhou J.B., Patel T.R., Sirianni R.W., Strohbehn G., Zheng M.Q., Duong N., Schafbauer T., Huttner A.J., Huang Y.Y., Carson R.E., Zhang Y., Sullivan D.J., Piepmeier J.M., Saltzman W.M. Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(29):11751-11756.
18. Mohanraj V.J.C., Y. Nanoparticles-a review. Trop. J. Pharm. Res. 2006, 5(1):561-573.
19. Freiberg S., Zhu X. Polymer microspheres for controlled drug release. Int. J. Pharm. 2004, 282(1-2):1-18.
20. Edlund U., Albertsson A.C. Degradable polymer microspheres for controlled drug delivery,. Degradable Aliphatic Polyesters 2002, 157:67-112.
21. Park J.H., Ye M.L., Park K. Biodegradable polymers for microencapsulation of drugs. Molecules 2005, 10(1):146-161.
22. Vilos C., Velasquez L.A. Therapeutic strategies based on polymeric microparticles. J. Biomed. Biotechnol. 2012, 2012. Article ID 672760.
23. Hu L., Zhang H., Song W. An overview of preparation and evaluation sustained-release injectable microspheres. J. Microencapsul. 2013, 30(4):369-382.
24. Tran V.T., Benoit J.P., Venier-Julienne M.C. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy?. Int. J. Pharm. 2011, 407(1-2):1-11.
25. Lemaire L., Roullin V.G., Franconi F., Venier-Julienne M.C., Menei P., Jallet P., Le Jeune J.J., Benoit J.P. Therapeutic efficacy of 5-fluorouracil-loaded microspheres on rat glioma: a magnetic resonance imaging study. NMR Biomed. 2001, 14(6):360-366.
26. Elkharraz K., Faisant N., Guse C., Siepmann F., Arica-Yegin B., Oger J.M., Gust R., Goepferich A., Benoit J.P., Siepmann J. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. Int. J. Pharm. 2006, 314(2):127-136.
27. Zhang H., Gao S. Temozolomide/PLGA microparticles and antitumor activity against Glioma C6 cancer cells in vitro. Int. J. Pharm. 2007, 329(1-2):122-128.
28. Zhang Y.H., Yue Z.J., Zhang H., Tang G.S., Wang Y., Liu J.M. Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model. Eur. J. Pharm. Biopharm. 2010, 76(3):371-375.
29. Gil-Alegre M.E., Gonzalez-Alvarez I., Gutierrez-Pauls L., Torres-Suarez A.I. Three weeks release BCNU loaded hydrophilic-PLGA microspheres for interstitial chemotherapy: development and activity against human glioblastoma cells. J. Microencapsul. 2008, 25(8):561-568.
30. Chen W., Lu D.R. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization. J. Microencapsul. 1999, 16(5):551-563.
31. Menei P., BoisdronCelle M., Croue A., Guy G., Benoit J.P. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery 1996, 39(1):117-123.
32. Menei P., Capelle L., Guyotat J., Fuentes S., Assaker R., Bataille B., Francois P., Dorwling-Carter D., Paquis P., Bauchet L., Parker F., Sabatier J., Faisant N., Benoit J.P. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery 2005, 56(2):242-247.
33. Menei P., Jadaud E., Faisant N., Boisdron-Celle M., Michalak S., Fournier D., Delhaye M., Benoit J.P. Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma-a phase I study. Cancer 2004, 100(2):405-410.
34. Menei P., Venier M.C., Gamelin E., Saint-Andre J.P., Hayek G., Jadaud E., Fournier D., Mercier P., Guy G., Benoit J.P. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma-a pilot study. Cancer 1999, 86(2):325-330.
35. Fournier E., Passirani C., Montero-Menei C., Colin N., Breton P., Sagodira S., Menei P., Benoit J.P. Therapeutic effectiveness of novel 5-fluorouracil-loaded poly(methylidene malonate 2.1.2)-based microspheres on F98 glioma-bearing rats. Cancer 2003, 97(11):2822-2829.
36. Roullin V.G., Deverre J.R., Lemaire L., Hindre F., Venier-Julienne M.C., Vienet R., Benoit J.P. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [H-3](6)-5-fluorouracil-loaded PLGA microspheres. Eur. J. Pharm. Biopharm. 2002, 53(3):293-299.
37. Roullin V.G., Mege M., Lemaire L., Cueyssac J.P., Venier-Julienne M.C., Menei P., Gamelin E., Benoit J.P. Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization. Pharm. Res. 2004, 21(9):1558-1563.
38. Reza M.S., Whateley T.L. Iodo-2'-deoxyuridine (IUdR) and (125)IUdR loaded biodegradable microspheres for controlled delivery to the brain. J. Microencapsul. 1998, 15(6):789-801.
39. Pradilla G., Wang P.P., Gabikian P., Li K., Magee C.A., Walter K.A., Brem H. Local intracerebral administration of paclitaxel with the Paclimer (R) delivery system: toxicity study in a canine model. J. Neuro-Oncol. 2006, 76(2):131-138.
40. Emerich D.F., Winn S.R., Bartus R.T. Injection of chemotherapeutic microspheres and glioma IV: eradicating tumors in rats. Cell Transplant. 2001, 11(1):47-54.
41. Emerich D.F., Winn S.R., Hu Y.H., Marsh J., Snodgrass P., LaFreniere D., Wiens T., Hasler B.P., Bartus R.T. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors. Pharm. Res. 2000, 17(7):767-775.
42. Emerich D.F., Winn S.R., Snodgrass P., LaFreniere D., Agostino M., Wiens T., Xiong H., Bartus R.T. Injectable chemotherapeutic microspheres and glioma II: Enhanced survival following implantation into deep inoperable tumors. Pharm. Res. 2000, 17(7):776-781.
43. Fournier E., Passirani C., Colin N., Breton P., Sagodira S., Benoit J.P. Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers. Eur. J. Pharm. Biopharm. 2004, 57(2):189-197.
44. Boisdroncelle M., Menei P., Benoit J.P. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. J. Pharm. Pharmacol. 1995, 47(2):108-114.
45. Benny O., Duvshani-Eshet M., Cargioli T., Bello L., Bikfalvi A., Carroll R.S., Machluf M. Continuous delivery of endogenous inhibitors from poly (lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth. Clin. Cancer Res. 2005, 11(2):768-776.
46. Benny O., Kim S.K., Gvili K., Radzishevsky I.S., Mor A., Verduzco L., Menon L.G., Black P.M., Machluf M., Carroll R.S. In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model. FASEB J. 2008, 22(2):488-499.
47. Benny O., Menon L.G., Arid G., Goren E., Kim S.K., Stewman C., Black P.M., Carroll R.S., Machluf M. Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. Clin. Cancer Res. 2009, 15(4):1222-1231.
48. Chandy T., Das G.S., Rao G.H.R. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J. Microencapsul. 2000, 17(5):625-638.
49. Ozeki T., Hashizawa K., Kaneko D., Imai Y., Okada H. Treatment of rat brain tumors using sustained-release of camptothecin from poly(lactic-co-glycolic acid) microspheres in a thermoreversible hydrogel. Chem. Pharm. Bull. (Tokyo) 2010, 58(9):1142-1147.
50. Arai T., Benny O., Joki T., Menon L.G., Machluf M., Abe T., Carroll R.S., Black P.M. Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes. Anticancer Res. 2010, 30(4):1057-1064.
51. Hussain M., Beale G., Hughes M., Akhtar S. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer. Int. J. Pharm. 2002, 234(1-2):129-138.
52. Yemisci M., Bozdag S., Cetin M., Soylemezoglu F., Capan Y., Dalkara T., Vural I. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres. Neurosurgery 2006, 59(6):1296-1302. (discussion 1302-1293).
53. Emerich D.F., Winn S.R., Bartus R.T. Injection of chemotherapeutic microspheres and glioma III: Parameters to optimize efficacy. Cell Transplant. 2001, 11(1):35-45.
54. Song T.T., Yuan X.B., Sun A.P., Wang H., Kang C.S., Ren Y., He B., Sheng J., Pu P.Y. Preparation of injectable paclitaxel sustained release microspheres by spray drying for inhibition of glioma in vitro. J. Appl. Polym. Sci. 2009, 115(3):1534-1539.
55. Lin R., Shi Ng L., Wang C.H. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 2005, 26(21):4476-4485.
56. Xie J.W., Marijnissen J.C.M., Wang C.H. Microparticles developed by electrohyd ro dynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro. Biomaterials 2006, 27(17):3321-3332.
57. Xie J.W., Tan R.S., Wang C.H. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro. J. Biomed. Mater. Res. A 2008, 85A(4):897-908.
58. Ranganath S.H., Kee I., Krantz W.B., Chow P.K.H., Wang C.H. Hydrogel matrix entrapping PLGA-paclitaxel microspheres: drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy. Pharm. Res. 2009, 26(9):2101-2114.
59. Naraharisetti P.K., Ong B.Y.S., Xie J.W., Lee T.K.Y., Wang C.H., Sahinidis N.V. In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma. Biomaterials 2007, 28(5):886-894.
60. Li K.W., Dang W.B., Tyler B.M., Troiano G., Tihan T., Brem H., Walter K.A. Polilactofate microspheres for paclitaxel delivery to central nervous system malignancies. Clin. Cancer Res. 2003, 9(9):3441-3447.
61. Floyd J.A., Galperin A., Ramakrishna R., Rostomily R., Ratner B.D. Drug Encapsulated Aerosolized Microspheres as a Biodegradable, Intelligent Glioma Therapy. Society for Biomaterials 2014 Annual Meeting & ExpositionDenver, CO 2014.
62. de la Ossa D.H.P., Lorente M., Gil-Alegre M.E., Torres S., Garcia-Taboada E., Aberturas M.D., Molpeceres J., Velasco G., Torres-Suarez A.I. Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme. PLoS ONE 2013, 8(1):e54795.
63. Ozeki T., Kaneko D., Hashizawa K., Imai Y., Tagami T., Okada H. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel (vol 427, pg 299, 2012). Int. J. Pharm. 2012, 430(1-2):393.
64. Zhang D.Y., Tian A., Xue X.X., Wang M., Qiu B., Wu A.H. The effect of temozolomide/poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behavior. Int. J. Mol. Sci. 2012, 13(1):1109-1125.
65. Araki T., Yashima H., Shimizu K., Aomori T., Hashita T., Kaira K., Nakamura T., Yamamoto K. Review of the treatment of non-small cell lung cancer with gefitinib. Clin. Med. Insights Oncol. 2012, 6:407-421.
66. Floyd J.A., Galperin A., Ratner B.D. Drug Encapsulated Aerosolized Microspheres as a Localized, Degradable Cancer Therapy 2014, 2014 AIChE Annual Meeting Atlanta, GA.
67. Reguera-Nunez E., Roca C., Hardy E., de la Fuente M., Csaba N., Garcia-Fuentes M. Implantable controlled release devices for BMP-7 delivery and suppression of glioblastoma initiating cells. Biomaterials 2014, 35(9):2859-2867.
68. Rhines L.D., Sampath P., DiMeco F., Lawson H.C., Tyler B.M., Hanes J., Olivi A., Brem H. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma. Neurosurgery 2003, 52(4):872-879. (discussion 879-880).
69. Beer S.J., Matthews C.B., Stein C.S., Ross B.D., Hilfinger J.M., Davidson B.L. Poly(lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo. Gene Ther. 1998, 5(6):740-746.
70. Gabikian P., Tyler B.M., Zhang I., Li K.W., Brem H., Walter K.A. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres Laboratory investigation. J. Neurosurg. 2014, 120(5):1078-1085.
71. Ozeki T., Kaneko D., Hashizawa K., Imai Y., Tagami T., Okada H. Combination therapy of surgical tumor resection with implantation of a hydrogel containing camptothecin-loaded poly(lactic-co-glycolic acid) microspheres in a C6 Rat glioma model. Biol. Pharm. Bull. 2012, 35(4):545-550.
72. Zhang Y.H., Zhang H., Liu J.M., Yue Z.J. Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats. Med. Oncol. 2011, 28(3):901-906.
73. Dong J., Zhou G.H., Tang D.F., Chen Y.M., Cui B.Q., Dai X.L., Zhang J.S., Lan Q., Huang Q. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth. J. Cancer Res. Clin. Oncol. 2012, 138(12):2079-2084.
74. Allhenn D., Neumann D., Beduneau A., Pellequer Y., Lamprecht A. A "drug cocktail" delivered by microspheres for the local treatment of rat glioblastoma. J. Microencapsul. 2013, 30(7):667-673.
75. Hanes J., Sills A., Zhao Z., Suh K.W., Tyler B., DiMeco F., Brat D.J., Choti M.A., Leong K.W., Pardoll D.M., Brem H. Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. Pharm. Res. 2001, 18(7):899-906.
76. Hsu W., Lesniak M.S., Tyler B., Brem H. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma. J. Neuro-Oncol. 2005, 74(2):135-140.